EZH2 Suppression Diversifies Prostate Cancer Lineage Variant Evolution and Lacks Efficacy in Inhibiting Disease Progression.
Saved in:
| Title: | EZH2 Suppression Diversifies Prostate Cancer Lineage Variant Evolution and Lacks Efficacy in Inhibiting Disease Progression. |
|---|---|
| Authors: | Jacobi JJ; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Wadosky KM; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Jaiswal N; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Zhang X; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Wang Y; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Singh PK; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Wang J; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Cortes Gomez E; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Wang J; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Xu B; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Long MD; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Cejas P; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Kukreja S; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Long HW; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Goodrich DW; Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York. |
| Source: | Cancer research [Cancer Res] 2026 Feb 16; Vol. 86 (4), pp. 889-908. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41223330 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: EZH2 Suppression Diversifies Prostate Cancer Lineage Variant Evolution and Lacks Efficacy in Inhibiting Disease Progression. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jacobi+JJ%22">Jacobi JJ</searchLink>; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.<br /><searchLink fieldCode="AU" term="%22Wadosky+KM%22">Wadosky KM</searchLink>; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.<br /><searchLink fieldCode="AU" term="%22Jaiswal+N%22">Jaiswal N</searchLink>; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.<br /><searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.<br /><searchLink fieldCode="AU" term="%22Singh+PK%22">Singh PK</searchLink>; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.<br /><searchLink fieldCode="AU" term="%22Cortes+Gomez+E%22">Cortes Gomez E</searchLink>; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.<br /><searchLink fieldCode="AU" term="%22Xu+B%22">Xu B</searchLink>; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.<br /><searchLink fieldCode="AU" term="%22Long+MD%22">Long MD</searchLink>; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.<br /><searchLink fieldCode="AU" term="%22Cejas+P%22">Cejas P</searchLink>; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Kukreja+S%22">Kukreja S</searchLink>; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Long+HW%22">Long HW</searchLink>; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Goodrich+DW%22">Goodrich DW</searchLink>; Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222984705R%22">Cancer research</searchLink> [Cancer Res] 2026 Feb 16; Vol. 86 (4), pp. 889-908. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>2984705R <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-7445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200085472%22">00085472 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41223330 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/0008-5472.CAN-25-2747 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 889 Titles: – TitleFull: EZH2 Suppression Diversifies Prostate Cancer Lineage Variant Evolution and Lacks Efficacy in Inhibiting Disease Progression. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jacobi JJ – PersonEntity: Name: NameFull: Wadosky KM – PersonEntity: Name: NameFull: Jaiswal N – PersonEntity: Name: NameFull: Zhang X – PersonEntity: Name: NameFull: Wang Y – PersonEntity: Name: NameFull: Singh PK – PersonEntity: Name: NameFull: Wang J – PersonEntity: Name: NameFull: Cortes Gomez E – PersonEntity: Name: NameFull: Wang J – PersonEntity: Name: NameFull: Xu B – PersonEntity: Name: NameFull: Long MD – PersonEntity: Name: NameFull: Cejas P – PersonEntity: Name: NameFull: Kukreja S – PersonEntity: Name: NameFull: Long HW – PersonEntity: Name: NameFull: Goodrich DW IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 02 Text: 2026 Feb 16 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1538-7445 Numbering: – Type: volume Value: 86 – Type: issue Value: 4 Titles: – TitleFull: Cancer research Type: main |
| ResultId | 1 |